Concepedia

Rhona Stein

RS

53

Publications

3.3K

Citations

36

H-Index

1962

Active since

Affiliations

Center for Molecular Medicine and Immunology(Current)

Immunomedics (United States)

Cornell University

Rhona Stein is an author at Center for Molecular Medicine and Immunology specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1962–2012

53

Publications

53

Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines.

Chris Waskewich, Rosalyn D. Blumenthal, Honglan Li et al. · PubMed · 2002 · 203 citations

, , +14

Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody.

David M. Goldenberg, Jo Ann Horowitz, Robert M. Sharkey et al. · Journal of Clinical Oncology · 1991 · 202 citations

, , +14

Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab

Josette Carnahan, Rhona Stein, Zhengxing Qu et al. · Molecular Immunology · 2006 · 173 citations

, , +8

Characterization of a New Humanized Anti-CD20 Monoclonal Antibody, IMMU-106, and Its Use in Combination with the Humanized Anti-CD22 Antibody, Epratuzumab, for the Therapy of Non-Hodgkin’s Lymphoma

Rhona Stein, Zhengxing Qu, Susan Chen et al. · Clinical Cancer Research · 2004 · 170 citations · Full text

Anti-CD74 Antibody-Doxorubicin Conjugate, IMMU-110, in a Human Multiple Myeloma Xenograft and in Monkeys

Puja Sapra, Rhona Stein, J. Pickett et al. · Clinical Cancer Research · 2005 · 168 citations

Rows per page

1–5 of 53